In vitro α–Glucosidase Inhibition, Cytotoxicity, SAR, Swiss ADME Prediction and Molecular Docking Study of New N –Substituted Hydantoin Derivatives
ChemistryOpen · 2025-04 · 14 (4)
DOI: 10.1002/open.202400119 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistryOpen, online erschienen am 03.02.2025. Verfasst von Ndivhuwo R Tshiluka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Synthesis and Catalysis, Department of Chemical Sciences, University of Johannesburg, Kingsway Campus, P.O. Auckland Park 2006, S…. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, alpha-Glucosidases, Hydantoins, Hypoglycemic Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the University of Johannesburg Research Committee (URC) and the Research Centre for Synthesis and Catalysis (RCSC), the National Research Foundation (NRF) of South Africa and the Sasol Inzalo Foundation, THUTHUKA research funds.
Abstract (Originalsprache)
Diabetes is a chronic metabolic disorder affecting about 463 million people globally. α‐Glucosidase (EC.3.2.1.20) inhibitors are among the FDA‐approved oral anti‐diabetic medications used to treat type 2 diabetes. In search of new potential α‐glucosidase inhibitors, fifteen of our previously synthesized hydantoin derivatives 8 a – o were evaluated for their antidiabetic activity. All compounds 8 a – o showed weak α‐glucosidase inhibition at 10, 50 and 100 μM. However, at 200 μM, compound 8 o was the most potent among the series followed by compounds 8 a, 8 d, 8 l and 8 n exhibiting moderate inhibition. The established SAR depended upon the exchange of methyl with methoxy and dioxole derivatives at positions 3 and 4 of the phenyl ring. Cytotoxicity studies revealed that most of the compounds have no cytotoxic effect. Furthermore, Swiss ADME predictions of compounds 8 a , 8 d , 8 i , 8 l and 8 o showed high gastrointestinal intestinal absorption required for intestinal absorption of any drug. Most compounds did not obey drug‐likeness character since they violated Ghose and Veber rules with MW>350 and rotors>11. Molecular docking was carried out to investigate the binding interaction of compounds with the active site of α‐glucosidase. The results correlated well with those of the experimental, thereby contributing towards the development of new α‐glucosidase inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Centre for Synthesis and Catalysis, Department of Chemical Sciences, University of Johannesburg, Kingsway Campus, P.O. Auckland Park 2006, South Africa.
- Department of Biochemistry and Microbiology, University of Venda, Private Bag X5050, Thohoyandou, South Africa.
- Department of Chemistry, University of Venda, Private Bag X5050, Thohoyandou, South Africa.
ORCID-Profile: Ndivhuwo R Tshiluka
Förderung
- the University of Johannesburg Research Committee (URC) and the Research Centre for Synthesis and Catalysis (RCSC)
- the National Research Foundation (NRF) of South Africa and the Sasol Inzalo Foundation
- THUTHUKA research funds
Zitieren
APA
Tshiluka, N. R., Mbedzi, D. T., Bvumbi, M. V., & Mnyakeni-Moleele, S. S. (2025). In vitro α–Glucosidase Inhibition, Cytotoxicity, SAR, Swiss ADME Prediction and Molecular Docking Study of New N –Substituted Hydantoin Derivatives. ChemistryOpen, 14(4). https://doi.org/10.1002/open.202400119
Vancouver
Tshiluka NR, Mbedzi DT, Bvumbi MV, Mnyakeni-Moleele SS. In vitro α–Glucosidase Inhibition, Cytotoxicity, SAR, Swiss ADME Prediction and Molecular Docking Study of New N –Substituted Hydantoin Derivatives. ChemistryOpen. 2025;14(4). doi:10.1002/open.202400119
BibTeX
@article{Tshiluka2025,
author = {Tshiluka, Ndivhuwo R and Mbedzi, Dakalo T and Bvumbi, Mpelegeng V and Mnyakeni-Moleele, Simon S},
title = {In vitro α–Glucosidase Inhibition, Cytotoxicity, SAR, Swiss ADME Prediction and Molecular Docking Study of New N –Substituted Hydantoin Derivatives},
journal = {ChemistryOpen},
year = {2025},
volume = {14},
number = {4},
doi = {10.1002/open.202400119}
}
EUVIMED